Literature DB >> 22828153

Indication for surgery and the risk of postoperative nausea and vomiting after craniotomy: a case-control study.

Christine Tan1, Craig R Ries, Kelly Mayson, Angineh Gharapetian, Donald E G Griesdale.   

Abstract

BACKGROUND: The primary hypothesis of the study is that acoustic neuroma (AN) surgery and microvascular decompression (MVD) of cranial nerves increase the risk of postoperative nausea and vomiting (PONV).
METHODS: We designed a retrospective case-control study matched on age, sex, and year of surgery (≤2005 and >2005). Year of surgery was noted as a potential confounder, because routine antiemetic prophylaxis was strongly encouraged at the study site in 2005. Cases of PONV in the recovery room were matched to controls in a 1:2 manner using a perioperative database. Charts were then reviewed for the following data: American Society of Anesthesiologists grade, smoking status, craniotomy location, craniotomy indication, and type of anesthetic administered.
RESULTS: The final analysis included 117 cases that were matched with 185 controls. Patients had a mean age of 50 years (SD=13), and 65% were female. Overall, the majority of craniotomies were supratentorial (70%) and performed for tumor resection (41%). On multivariable analysis, MVD [odds ratio (OR)=6.7; 95% confidence interval (CI), 2.0-22.7; P=0.002], AN (OR=3.3; 95% CI, 1.0-11.0; P=0.05), and epilepsy surgery (OR=2.8; 95% CI, 1.1-7.5; P=0.04) were associated with an increased likelihood of PONV when compared with tumor surgery. There was effect modification of total intravenous anesthesia by location of surgery (P-interaction=0.02). The benefit of total intravenous anesthesia on PONV was observed in supratentorial (OR=0.41; 95% CI, 0.17-0.96; P=0.04) but not infratentorial location (OR=2.6; 95% CI, 0.78-8.7; P=0.11).
CONCLUSIONS: MVD and AN resection were associated with an increased likelihood of PONV compared with craniotomies performed for other tumor resection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22828153     DOI: 10.1097/ANA.0b013e3182611a30

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  5 in total

1.  Is microvascular decompression surgery a high risk for postoperative nausea and vomiting in patients undergoing craniotomy?

Authors:  Keita Sato; Seijyu Sai; Takehiko Adachi
Journal:  J Anesth       Date:  2013-05-07       Impact factor: 2.078

2.  Effects of Intraoperative Dexamethasone and Ondansetron on Postoperative Nausea and Vomiting in Microvascular Decompression Surgery: A Randomized Controlled Study.

Authors:  Cattleya Thongrong; Patitha Chullabodhi; Pornthep Kasemsiri; Amnat Kitkhuandee; Narin Plailaharn; Lumyai Sabangban; Thirada Jimarsa
Journal:  Anesthesiol Res Pract       Date:  2018-11-11

3.  Successful implementation of an enhanced recovery after surgery (ERAS) protocol reduces nausea and vomiting after infratentorial craniotomy for tumour resection: a randomized controlled trial.

Authors:  Dan Lu; Yuan Wang; Tianzhi Zhao; Bolin Liu; Lin Ye; Lanfu Zhao; Binfang Zhao; Mingjuan Li; Lin Ma; Zhengmin Li; Jiangtao Niu; Wenhai Lv; Yufu Zhang; Tao Zheng; Yafei Xue; Lei Chen; Long Chen; Xude Sun; Guodong Gao; Bo Chen; Shiming He
Journal:  BMC Neurol       Date:  2020-04-22       Impact factor: 2.474

4.  Comparison of the antiemetic effect of ramosetron with ondansetron in patients undergoing microvascular decompression with retromastoid craniotomy: a preliminary report.

Authors:  Sang Hee Ha; Hyunzu Kim; Hyang Mi Ju; Da Jung Nam; Kyeong Tae Min
Journal:  Korean J Anesthesiol       Date:  2015-07-28

Review 5.  Postoperative Nausea and Vomiting After Craniotomy: An Evidence-based Review of General Considerations, Risk Factors, and Management.

Authors:  Alberto A Uribe; Nicoleta Stoicea; Marco Echeverria-Villalobos; Alexandre B Todeschini; Alan Esparza Gutierrez; Antonia R Folea; Sergio D Bergese
Journal:  J Neurosurg Anesthesiol       Date:  2021-07-01       Impact factor: 3.956

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.